Project Grant R03EB038033
- The National Institute of Biomedical Imaging and Bioengineering awarded Brigham & Women's Hospital Inc. $1,583,125 on May 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a multifunctional interventional device for biopsy and optical imaging-based phase-0 drug response measurements. The recipient will develop an interventional drug response assay (IDRA) device to enable biopsy-based phase-0 measurements...
- Summary of Federal Project Grant Award Brigham & Women's Hospital Inc. received a $1.554 million Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a trackerless surgical navigation system for minimally invasive liver surgery. The award, dated August 1, 2025, with performance extending through July 31, 2029, funds the...
- The National Cancer Institute awarded Brigham & Women's Hospital $711,696 on July 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to modernize and modularize 3D Slicer, an open-source medical imaging software platform used in cancer research. The project will rearchitect 3D Slicer's core architecture into logical, reusable building block packages deployable across cloud, workstation, and web browser environments, reducing code duplication and accelerating...
- The National Institute of Biomedical Imaging and Bioengineering awarded The General Hospital Corporation (Massachusetts General Hospital) $206,250 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and evaluate the feasibility of an integrated mechano-arthroscope for minimally invasive assessment of joint tissue pathology and micromechanics. The project addresses a gap in arthritis diagnosis: current...
- The National Institute of Biomedical Imaging and Bioengineering awarded Northeastern University $219,818 on April 27, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop a fully integrated electro-optic sensor for real-time MRI-guided interventions. The award funds development of an interventional device sensor that addresses safety and imaging limitations in MRI-guided procedures. Current active devices for...
- The National Institute of Biomedical Imaging and Bioengineering awarded The Children's Hospital Corporation (Boston Children's Hospital) $267,000 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop and expand the Fetal and Neonatal Development Imaging (FEDI) open-source software platform for analyzing early brain development via magnetic resonance imaging. The project addresses a critical gap in...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital $656,750 through the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 1, 2025, for a three-year project period concluding July 31, 2028. The award funds research to develop and optimize Electrical Impedance Tomography (EIT) as a bedside imaging tool for assessing lung perfusion in acute...
- The National Institute of Biomedical Imaging and Bioengineering awarded Brigham and Women's Hospital Inc. $268,500 on August 20, 2026, to develop and validate a biomimetic palpation system for intraoperative lung nodule localization and margin assessment during minimally invasive lung cancer surgery. The award funds development of BiopalP, a novel tactile-sensing device that integrates multimodal haptic feedback with deep learning algorithms to enable surgeons to accurately localize small lung...
- The National Institute of Biomedical Imaging and Bioengineering awarded Massachusetts General Hospital (doing business as The General Hospital Corporation's Research Management Division) $199,616 on May 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286, K99 Project Grant). The award funds development of a deep learning method that fuses three data sources—clinical notes, lab results, and images—to improve disease...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Virginia $190,847 on June 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop force-based metrics and haptic feedback technology for robotic paraesophageal hernia repair. The research will establish objective performance indicators for complex surgical procedures by integrating force-sensing technology and haptic feedback...
The National Institute of Biomedical Imaging and Bioengineering awarded Brigham & Women's Hospital Inc. one dollar on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to enhance the interoperability and reusability of SlicerROS2, an open-source software platform for image-guided and robot-assisted interventions (IGRIS). The project aims to promote the Findable, Accessible, Interoperable, and Reusable (FAIR4RS) principles for research software supporting IGRIS. The work addresses a clinical need: globally, more than 232 million surgeries and interventions occur annually, with complication rates reaching up to 20 percent. IGRIS research is exploring ways to aid surgeons in identifying and accessing lesions with minimal invasion, but deployment has been hampered by mismatches between preoperative anatomical maps and actual surgical fields caused by patient motion and other uncertainties. The research community has shifted from hardware-centric to software-centric approaches emphasizing advanced control algorithms, machine learning, and artificial intelligence. This shift relies on modular software development using platforms such as the Robot Operating System (ROS) for robotics and 3D Slicer for medical image computing. However, integrating these diverse software components for IGRIS presents unique technical challenges that SlicerROS2 is designed to address. The period of performance runs through August 31, 2028. Work is performed in Massachusetts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1 | 8/21/26 |